G. Siregar, R. Paramesh, R. Kumawat, P. D, and S. HA, “A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease”, Eur J Clin Exp Med, vol. 19, no. 2, pp. 129–136, Jun. 2021.